Literature DB >> 32042616

Enhanced power bacillus Calmette-Guérin-possibly too much of a good thing.

Wojciech Krajewski1, Sławomir Poletajew2.   

Abstract

Entities:  

Year:  2019        PMID: 32042616      PMCID: PMC6989861          DOI: 10.21037/tau.2019.10.08

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
  5 in total

1.  Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.

Authors:  Jakob Hedegaard; Philippe Lamy; Iver Nordentoft; Ferran Algaba; Søren Høyer; Benedicte Parm Ulhøi; Søren Vang; Thomas Reinert; Gregers G Hermann; Karin Mogensen; Mathilde Borg Houlberg Thomsen; Morten Muhlig Nielsen; Mirari Marquez; Ulrika Segersten; Mattias Aine; Mattias Höglund; Karin Birkenkamp-Demtröder; Niels Fristrup; Michael Borre; Arndt Hartmann; Robert Stöhr; Sven Wach; Bastian Keck; Anna Katharina Seitz; Roman Nawroth; Tobias Maurer; Cane Tulic; Tatjana Simic; Kerstin Junker; Marcus Horstmann; Niels Harving; Astrid Christine Petersen; M Luz Calle; Ewout W Steyerberg; Willemien Beukers; Kim E M van Kessel; Jørgen Bjerggaard Jensen; Jakob Skou Pedersen; Per-Uno Malmström; Núria Malats; Francisco X Real; Ellen C Zwarthoff; Torben Falck Ørntoft; Lars Dyrskjøt
Journal:  Cancer Cell       Date:  2016-06-16       Impact factor: 31.743

2.  Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.

Authors:  David Liu; Elizabeth R Plimack; Jean Hoffman-Censits; Levi A Garraway; Joaquim Bellmunt; Eliezer Van Allen; Jonathan E Rosenberg
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

3.  The BCG Shortage.

Authors:  Edward M Messing
Journal:  Bladder Cancer       Date:  2017-07-27

Review 4.  Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer.

Authors:  Yuqing Liu; Jian Lu; Yi Huang; Lulin Ma
Journal:  J Oncol       Date:  2019-03-10       Impact factor: 4.375

5.  In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.

Authors:  Dunia Rodriguez; Cibelly Goulart; Ana C Pagliarone; Eliane P Silva; Priscila S Cunegundes; Ivan P Nascimento; Ricardo C Borra; Waldely O Dias; Aldo Tagliabue; Diana Boraschi; Luciana C C Leite
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.